DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for tibial collateral ligament bursitis — screening already-approved drugs against its 1-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleTibial collateral ligament bursitis maps to a 1-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for tibial collateral ligament bursitis is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
Molecular view
methyl-CpG binding domain protein 2 (MBD2) — MBD2 is one of the genes genetically linked to this disease in Open Targets — shown as context, not as a drug target we're pursuing: no approved-drug candidate for this disease is yet corroborated in the literature we found.
Loading structure…
helix sheet ihpdrag to rotate · scroll to zoom
RCSB Protein Data Bank · entry 7AO8 · 4.5 Å · ligand INOSITOL HEXAKISPHOSPHATE (IHP). Experimental structure, not a prediction.
What the evidence adds up to
In 91 patients evaluated between 1982 and 1985, tibial collateral ligament bursitis was diagnosed based on tenderness over the ligament at the joint line without mechanical symptoms. With a nonsurgical program, 62% of patients improved and required no further treatment. Fifteen percent did not improve; of that group, one-third had a negative arthrogram or arthroscopy. Another 23% did not improve and ultimately underwent an arthroscopic partial medial meniscectomy.
The bursa of the tibial collateral ligament may be visualised at magnetic resonance imaging when distended with fluid. In the authors’ experience of seven cases, this finding signifies a pathologic condition either in the medial capsuloligamentous complex or in the bursa itself, and may indicate tibial collateral ligament bursitis. Prolonged relief of symptoms after injection of steroid into the bursa is supportive of the diagnosis. The differential diagnosis for the MR findings is discussed.
Most inflamed knee bursae, including those of the tibial collateral ligament, can be treated conservatively with aspiration of fluid, rest, ice, immobilisation, and injection of a corticosteroid and analgesic combination. Some chronic bursitic conditions may require surgical excision of the bursa.
What is still missing is any randomised controlled trial comparing these interventions, any data on long-term recurrence rates beyond the 1988 cohort, and any stratification of patients by imaging findings or by failure of initial conservative care. No drug repurposing data exist for this condition.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
Radiology · 1991 · 54 citations
Tibial collateral ligament bursa: MR imaging.
AbstractThe bursa of the tibial collateral ligament (TCL) may be visualized at magnetic resonance (MR) imaging when it becomes distended with fluid. In the authors' experience, this finding signifies a pathologic condition either in the medial capsuloligamentous complex or in the bursa itself. Such a finding may indicate TCL bursitis. TCL bursitis can be suspected in the setting of isolated pain in the medial joint line in the absence of mechanical symptoms. Prolonged relief of symptoms after injection of steroid into the bursa is supportive of the diagnosis. Seven cases are presented in which a fluid-filled TCL bursa was identified at MR imaging. In five cases, TCL bursitis was suspected. The differential diagnosis for the MR findings is discussed.
The American Journal of Sports Medicine · 1988 · 34 citations
Tibial collateral ligament bursitis
AbstractIn 91 patients evaluated between 1982 and 1985, tibial collateral ligament bursitis was diagnosed. This entity has not been described since the work of Brantigan and Voshell in 1943. The diagnosis was based on the findings of tenderness over the tibial collateral ligament at the joint line, without a history of mechanical symptoms. With a nonsurgical program, 62% of the patients improved and subsequently required no further treatment. Fifteen percent did not improve; of this group, one-third had a negative arthrogram or arthroscopy. Another 23% did not improve and ultimately underwent an arthroscopic partial medial meniscectomy. Tibial collateral ligament bursitis is an entity that should be considered in any patient with medial joint pain in the knee. Treatment is simple, effective, and offers low morbidity.
The American Journal of Sports Medicine · 2002 · 27 citations
Preventing Teenage Pregnancy, Childbearing, and Sexually Transmitted Diseases: What the Research Shows. American Teens. Child Trends Research Brief.
AbstractIn 91 patients evaluated between 1982 and 1985, tibial collateral ligament bursitis was diagnosed. This entity has not been described since the work of Brantigan and Voshell in 1943. The diagnosis was based on the findings of tenderness over the tibial collateral ligament at the joint line, without a history of mechanical symptoms. With a nonsurgical program, 62% of the patients improved and subsequently required no further treatment. Fifteen percent did not improve; of this group, one-third had a negative arthrogram or arthroscopy. Another 23% did not improve and ultimately underwent an arthroscopic partial medial meniscectomy. Tibial collateral ligament bursitis is an entity that should be considered in any patient with medial joint pain in the knee. Treatment is simple, effective, and offers low morbidity.
The Physician and Sportsmedicine · 1992 · 12 citations
Conservative Treatment of Inflamed Knee Bursae
AbstractIn brief Knee bursitis often mimics other brief Pathologies, making correct diagnosis necessary to initiate appropriate treatment. Most commonly affected are the prepatellar, pes anserine, tibial collateral ligament, and two infrapatellar bursae. Other common bursitic conditions include Baker's cysts and posttraumatic adventitious hemorrhagic bursitis. Most of these can be treated conservatively with aspiration of fluid from the bursa, rest, ice, immobilization, and injection of a corticosteroid and analgesic combination. Some chronic bursitic conditions may require surgical excision of the bursa.
Medicina dello Sport · 2021 · 0 citations · open access
Ultrasound-guided percutaneous treatment of calcific bursitis of the medial collateral ligament of the knee
AbstractCalcific bursitis of the medial collateral ligament of the knee is an infrequent pathological condition. In 1988, Kerlan and Glousman identified the clinical features of medial collateral ligament bursitis. Pain and knee functions limitation are the clinical symptoms that are most frequently encountered during the reactive inflammatory process in the bursa, that characterizes the reabsorption phases of the calcific material. It is well documented in the literature that the maximum efficacy of ultrasound-guided percutaneous treatment, with significant reduction or disappearance of symptoms, occurs precisely in this phase. The case report presented in this study confirms the validity as a therapeutic option of the ultrasound-guided percutaneous treatment, performed with the single-needle technique, in subjects with calcific bursitis of the medial collateral ligament. In particular, this procedure is minimally invasive, well tolerated by the patient, inexpensive, fast, not burdened by particular complications, as the ultrasound guide allows to avoid contact with adjacent structures.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
